MT MTSI MACOM Technology Solutions Загрузка... : Бычьи и медвежьи мнения аналитиков

Co-mentioned as one of five plays on projected CW Laser market growth from ~$1B to ~$10B by 2030; no personal position disclosed by author.

Cited as existing proof-of-concept for IQE customer relationships; no independent thesis or directional call on MTSI itself.

Reports Citi analysis of CW laser supply-demand gap; author unpacks implications for MTSI. No personal directional view.

MACOM has shown strong optical performance from its ~75mW CW laser and customers have tested and validated it, but the article explicitly points out that MACOM is 'still working through process stabilization and internal reliability before module qualification and hyperscaler approval', and management 'guided investors away from including meaningful CW revenue in fiscal 2026 or even fiscal 2027 models'. This suggests MACOM will likely miss the early phases of the CW ramp, reducing its near-term upside. Risk: Even after qualification, MACOM may face capacity constraints or pricing pressure compared to earlier-movers like Lumentum and Coherent.

Watch MTSI (MACOM) as a strategic investor in IQE with board involvement and £45M commitment tied to long-term agreements — supply-chain read-through to InP photonics.

Author provides a factual supply-chain analysis of CPO laser leaders and dismisses AAOI and MTSI, but does not state a personal position or forward call, so all tickers default to watch.

Goldman projects massive growth in AI optical component spend (15B→154B by 2028) and NVIDIA committed $2B each to Coherent/Lumentum, highlighting the entire optical supply chain as a potential beneficiary.

Watch COHR, MTSI, and LITE as competing/alternative laser suppliers to Sivers with known supply shortages; mentioned as competitive read-throughs in the InP laser TAM analysis, no author positions disclosed.

Watch MTSI as a secondary beneficiary in the optical interconnect supply chain after Musk's Mesh acquisition, though less directly tied.

Автор делится сравнительной таблицей и результатами исследования акций компаний в сфере связи, однако не выражает своей позиции и не дает прогнозов, предоставляя лишь фактический анализ для того, чтобы инвесторы могли сделать собственные выводы.

Упоминается в анализе фрагментации сектора связи как компания, демонстрирующая лучшие показатели; включена в статью о сравнительной оценке, рассматривающую ассортимент продукции, рост и мультипликаторы.

Автор перечисляет многочисленные тикеры в рамках готовящихся исследований и карт компаний, не указывая при этом текущих позиций или прогнозов, что переводит их все в разряд объектов для наблюдения.

Автор проводит исследование IQE как сложного процесса оздоровления компании с опциональностью в сфере оптических компонентов для ИИ и отмечает наличие множества сигналов в цепочке поставок, однако пока не открыл позицию.

Автор отмечает ежедневную фрагментацию акций в секторе связи, где компании, занимающиеся медью/оптикой, показывают лучшие результаты по сравнению с узкоспециализированными оптическими компаниями, однако рассматривает это как наблюдение за тенденцией и анонс исследования, а не как торговую рекомендацию.

MTSI упоминается как покупатель подразделения Wolfspeed по производству GaN на подложках SiC и поставщик GaN-усилителей для компании Filtronic для нужд космической связи; только в контексте цепочки поставок.

Указан наряду с CRDO в качестве поставщика чипсетов LRO/LPO для масштабирования объемов ИИ-сетей в ближайшей перспективе; автор не дает никаких явных направленных обязательств, помимо упоминания в одном контексте.

These merchant suppliers are in high demand due to capacity bottlenecks; watch for potential pricing power.

Watch MACOM — speculative mention as a potential CW laser supplier with remaining spare capacity that AMD could tap; no author position, framed as a possibility.

Buy MTSI as a co-supplier of LRO/LPO chipsets alongside CRDO, capturing near-term AI scale-up networking volume during the transition period before CPO ecosystem fully matures.

Co-mentioned as an existing IQE optical anchor foundry relationship in the AI photonics stack. No directional view from speaker.

Watch MTSI as a former Ayar Labs supplier; removed from website, but part of CPO supply-chain analysis.

The tweet presents a factual ranking of semiconductor companies by employee growth without expressing any personal position or forward-looking trade call.

MTSI co-mentioned as a performance benchmark in a comparative bullish thesis for SMTC; no independent directional view on MTSI stated.

Watch MTSI as context for the epiwafer supply-chain tightness thesis; its strategic investment into IQE to secure capacity highlights the criticality of the chokepoint, but no directional call or position is stated by the author.

Named as an alternative laser supplier in the AI optical chain with known laser shortages, co-mentioned alongside COHR and LITE in comparative supply analysis.

Watch COHR, MTSI, and LITE as competing/alternative laser suppliers to Sivers in the CPO market; laser shortages noted but these are competitive landscape names, not author-owned positions.

The author argues that photonics growth is driven by NPO and broader transceiver markets, not just CPO, so the CPO delay headline is overblown and the sector's TAM remains intact.

Research/context on photonics TAM after CPO/800V delay; no explicit buy/hold/current position or clear actionable long call, so strict semantics => watch.